Doyle Mittie bought CGEM
June 16, 2026 · Form 4 insider transaction
Doyle Mittie bought 21,781 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,781
Price
$0.00
Total value
N/A
InsiderDoyle Mittie
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 18, 2026
Shares owned after21,781
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option represents a right to purchase a total of 21,781 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 16, 2027 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.